ODN 2088
ODN 2088 is a potent TLR3, TLR7 and TLR9 inhibitor. ODN 2088 shows no cytotoxic. ODN 2088 inhibits the release of IFN-α and IL-6[1][2][3].
Product Specifications
CAS Number
1146541-45-8
UNSPSC
12352208
Target
Toll-like Receptor (TLR)
Type
Oligonucleotides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/odn-2088.html
Purity
98.82
Solubility
10 mM in DMSO
Smiles
[DNA,d(P-thio)(T-C-C-T-G-G-C-G-G-G-G-A-A-G-T)]
Molecular Weight
4878.00
References & Citations
[1]Römmler F, et al. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells. PLoS One. 2015 Feb 19;10 (2) :e0116703. |[2]Duramad O, et al. Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation. J Immunol. 2005 May 1;174 (9) :5193-200.|[3]Römmler F, et al. Guanine modification of inhibitory oligonucleotides potentiates their suppressive function. J Immunol. 2013 Sep 15;191 (6) :3240-53.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY420828 100 µg
EMA (MUC1) (NM_001044391) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC941176-500 1x 500 µL
EMI1 (EMI1/1176), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941474-100 1x 100 µL
ATRX / RAD54 (Alpha Thalassemia Mental Retardation) (23c), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470862-100 1x 100 µL
Glypican-3 (1G12), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 